Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials
Stroke remains an exceedingly incident and prevalent public health burden across the globe, with an estimated 16 million new strokes per annum and prevalence over 60 million, and extracranial internal carotid artery atherosclerotic disease is an important risk factor for stroke. Randomized trials of...
Main Authors: | Mark N Rubin, Kevin M Barrett, Thomas G Brott, James F Meschia |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-04-01
|
Series: | JRSM Cardiovascular Disease |
Online Access: | https://doi.org/10.1177/2048004014529419 |
Similar Items
-
Asymptomatic carotid stenosis: Are we under treating?
by: Edwin Stephen
Published: (2021-01-01) -
Can risk modelling improve treatment decisions in asymptomatic carotid stenosis?
by: James F. Burke, et al.
Published: (2019-11-01) -
Asymptomatic and Symptomatic Carotid Stenosis: An Obsolete Classification?
by: Anastasios Chatzikonstantinou, et al.
Published: (2012-01-01) -
Stent versus Surgery for Asymptomatic Carotid Stenosis
by: Preetam Krishnamurthy
Published: (2016-01-01) -
Gray matter asymmetry in asymptomatic carotid stenosis
by: Gao, L., et al.
Published: (2021)